A Study of Eribulin-Based Regimen Versus Other Chemotherpy in Triple-Negative Metastatic Breast Cancer (ERI-Based-01).

NCT05953909 · clinicaltrials.gov ↗

UNKNOWN

Status

120

Enrollment

OTHER_GOV

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Eribulin-Based Regimen
DRUG: nab-paclitaxel based regimen
DRUG: Other Chemotherapy Regimen

Sponsor

Fujian Cancer Hospital